Search - tctmd.com

Displaying 301 - 320 of 423

Sort: Relevancy | Date

News Conference News EuroPCR 2014

CENTURY II: Bioresorbable Polymer DES Stands up to Everolimus-Eluting Device

Caitlin E. Cox

May 20, 2014

News Daily News

Drug-Eluting Balloon Provides Strong Primary Patency in SFA at 1 Year

April 14, 2014

News Industry News

Texas Cardiac Arrhythmia Institute at St. David's Medical Center First in the United States to Use FDA-Approved ThermoCool® SmartTouch® Catheter

March 21, 2014

News Daily News

Collateral Flow Impacts Reperfusion, Outcome in Acute Ischemic Stroke

March 13, 2014

News Industry News

Abbott Completes Enrollment of Absorb™ Randomized Clinical Trials in the United States, Japan and China

March 10, 2014

News Daily News

First-Generation Bioresorbable Stent Performs Well in SFA Lesions

Jason Kahn

February 20, 2014

News Daily News

DUTCH PEERS Published: Third-Generation Zotarolimus, Everolimus Stents Equivalent

February 12, 2014

News Industry News

ARIAD and Medinol Announce Initiation of Two Registration Trials of the NIRsupreme™ Ridaforolimus-Eluting Stent for Use in Coronary Artery Disease

January 13, 2014

News Daily News

Bioresorbable Scaffolds Show Promise in Select STEMI Patients

Yael L. Maxwell

January 09, 2014

News Conference News AHA 2013

AHA 2013: Mix of Positive, Negative Trials Help Guide Interventional Practice

November 24, 2013

News Industry News

Comparison of Two Third-Generation Drug-Eluting Stents Establishes Comparable Safety and Efficacy; Demonstrates Non-Inferiority of Newest Zotarolimus-Eluting Stent

October 31, 2013

News Industry News

Removing Blood Clots during PCI Does Not Improve Outcomes Compared To Standard Angioplasty in Patients with Non-St-Elevation Myocardial Infarction

October 31, 2013

News Conference News TCT 2013

DUTCH PEERS: Third-Generation Stents Equivalent, Effective

October 31, 2013

News Conference News TCT 2013

Two Studies Examine Two-Stent Strategy vs. Provisional Stenting in Coronary Bifurcation Lesions

October 30, 2013

News Industry News

Tryton Medical Announces First Results From Pivotal Study of the Tryton Side Branch Stent™ Presented at TCT 2013 Annual Meeting in Late Breaking Clinical Trial Session

October 30, 2013

News Industry News

Clinical Trial Finds That A Strategy of Using a BMS in the Side Branch for True Bifurcation Coronary Lesions Is Safe, But Does Not Meet Non-Inferiority Endpoint Compared To Provisional Stenting

October 30, 2013

News Conference News TCT 2013

Bioresorbable Scaffold Stands Ground Next to Current DES

October 28, 2013

News Conference News TCT 2013

ABSORB III and IV Trials Aim to Prove Superiority of BVS

October 28, 2013

News Daily News

INFUSE-AMI: Thirty-Day Reduction in Infarct Size May Translate to 1-Year Benefit

Caitlin E. Cox

October 11, 2013

News Daily News

Failure to Give Pre-PCI Aspirin Not Infrequent Cause of Complications

Caitlin E. Cox

October 04, 2013

Advertisement

CENTURY II: Bioresorbable Polymer DES Stands up to Everolimus-Eluting Device

Drug-Eluting Balloon Provides Strong Primary Patency in SFA at 1 Year

Texas Cardiac Arrhythmia Institute at St. David's Medical Center First in the United States to Use FDA-Approved ThermoCool® SmartTouch® Catheter

Collateral Flow Impacts Reperfusion, Outcome in Acute Ischemic Stroke

Abbott Completes Enrollment of Absorb™ Randomized Clinical Trials in the United States, Japan and China

First-Generation Bioresorbable Stent Performs Well in SFA Lesions

DUTCH PEERS Published: Third-Generation Zotarolimus, Everolimus Stents Equivalent

ARIAD and Medinol Announce Initiation of Two Registration Trials of the NIRsupreme™ Ridaforolimus-Eluting Stent for Use in Coronary Artery Disease

Bioresorbable Scaffolds Show Promise in Select STEMI Patients

AHA 2013: Mix of Positive, Negative Trials Help Guide Interventional Practice

Comparison of Two Third-Generation Drug-Eluting Stents Establishes Comparable Safety and Efficacy; Demonstrates Non-Inferiority of Newest Zotarolimus-Eluting Stent

Removing Blood Clots during PCI Does Not Improve Outcomes Compared To Standard Angioplasty in Patients with Non-St-Elevation Myocardial Infarction

DUTCH PEERS: Third-Generation Stents Equivalent, Effective

Two Studies Examine Two-Stent Strategy vs. Provisional Stenting in Coronary Bifurcation Lesions

Tryton Medical Announces First Results From Pivotal Study of the Tryton Side Branch Stent™ Presented at TCT 2013 Annual Meeting in Late Breaking Clinical Trial Session

Clinical Trial Finds That A Strategy of Using a BMS in the Side Branch for True Bifurcation Coronary Lesions Is Safe, But Does Not Meet Non-Inferiority Endpoint Compared To Provisional Stenting

Bioresorbable Scaffold Stands Ground Next to Current DES

ABSORB III and IV Trials Aim to Prove Superiority of BVS

INFUSE-AMI: Thirty-Day Reduction in Infarct Size May Translate to 1-Year Benefit

Failure to Give Pre-PCI Aspirin Not Infrequent Cause of Complications

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content